Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists

Latest ARCH VENTURE CORP Stock Portfolio

$163Million

Equity Portfolio Value
Last Reported on: 14 Feb, 2024

About ARCH VENTURE CORP and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $163.5 Millions as of 31 Dec, 2023.

The top stock holdings of ARCH Venture Management, LLC are RVMD, VERV, ERAS. The fund has invested 56.7% of it's portfolio in REVOLUTION MEDICINES, INC. and 17.1% of portfolio in VERVE THERAPEUTICS, INC.

The fund managers got completely rid off EQRX, INC. (EQRX) stocks. They significantly reduced their stock positions in DENALI THERAPEUTICS, INC. (DNLI). ARCH Venture Management, LLC opened new stock positions in REVOLUTION MEDICINES, INC. (RVMD).

New Buys

Ticker$ Bought
REVOLUTION MEDICINES, INC.92,736,500

New stocks bought by ARCH VENTURE CORP

Additions

No additions were made to existing positions by ARCH VENTURE CORP

Reductions

Ticker% Reduced
DENALI THERAPEUTICS, INC.-45.05

ARCH VENTURE CORP reduced stake in above stock

Sold off

Ticker$ Sold
EQRX, INC.-80,664,500

ARCH VENTURE CORP got rid off the above stocks

Current Stock Holdings of ARCH VENTURE CORP

Last Reported on: 14 Feb, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
DNLIDENALI THERAPEUTICS, INC.5.00381,2498,181,600REDUCED-45.05
EQRXEQRX, INC.0.000.000.00SOLD OFF-100
ERASERASCA, INC.14.4011,055,60023,548,300UNCHANGED0.00
GOSSGOSSAMER BIO, INC.4.508,055,9207,351,020UNCHANGED0.00
OMICSINGULAR GENOMICS SYSTEMS, INC.1.073,798,9301,747,890UNCHANGED0.00
RVMDREVOLUTION MEDICINES, INC.56.723,233,49092,736,500NEW
UBXUNITY BIOTECHNOLOGY, INC.1.191,004,8201,939,300UNCHANGED0.00
VERVVERVE THERAPEUTICS, INC.17.132,008,81028,002,800UNCHANGED0.00